List of insiders holdings for ALPINE IMMUNE SCIENCES INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Alpine ImmunoSciences L.P. Alpine Bioventures GP LLC 10% Owner |
2023-11-13 21:15:27 | 4,266,215 0 |
4,266,215 | Form 13D |
| 2 | Venkatesan Jay Director 10% Owner |
2022-07-19 16:38:14 | 308,126 2,638,246 |
2,946,372 | Form 4 |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ISALY SAMUEL D Director 10% Owner |
2023-12-29 16:16:02 | 2,680,496 0 |
2,680,496 | Form 13D |
| 4 | Estate of Arnold H. Snider III 10% Owner |
2016-02-04 18:31:10 | 1,557,228 0 |
1,557,228 | Form 13G |
| 5 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner |
2023-02-13 17:57:24 | 1,353,815 0 |
1,353,815 | Form 13G |
| 6 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. DEERFIELD PRIVATE DESIGN FUND L P Deerfield Private Design Fund II L.P. Deerfield Private Design International L.P. Deerfield Private Design International II L.P. Possible Member of 10% Group 10% Owner |
2018-08-20 06:07:26 | 690,537 0 |
690,537 | Form 13D |
| 7 | Flynn James E DEERFIELD MANAGEMENT CO Director 10% Owner |
2018-08-20 06:07:26 | 690,537 0 |
690,537 | Form 13D |
| 8 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO DEERFIELD PRIVATE DESIGN FUND L P Deerfield Private Design International L.P. Deerfield Private Design Fund II L.P. Deerfield Private Design International II Ltd. Deerfield Special Situations Fund L.P. Possible Member of 10% Group 10% Owner |
2018-08-20 06:07:26 | 690,537 0 |
690,537 | Form 13D |
| 9 | TIGER PARTNERS LP Tiger Partners GP LLC 10% Owner |
2015-06-18 15:27:22 | 650,915 0 |
650,915 | Form 3 |
| 10 | Rock Springs Capital Management LP 10% Owner |
2015-06-24 16:09:30 | 0 564,358 |
564,358 | Form 4 |
| 11 | Hadley Harbor Master Investors (Cayman) L.P. 10% Owner |
2015-06-23 14:10:56 | 364,358 0 |
364,358 | Form 4 |
| 12 | Jennison Global Healthcare Master Fund Ltd. 10% Owner |
2015-06-22 18:26:21 | 329,780 0 |
329,780 | Form 4 |
| 13 | Hawkes Bay Master Investors (Cayman) L.P. 10% Owner |
2015-06-23 14:11:11 | 320,990 0 |
320,990 | Form 4 |
| 14 | Congleton Jon President and CEO |
2016-09-14 16:15:48 | 250,000 0 |
250,000 | Form 4 |
| 15 | Dummer Wolfgang Chief Medical Officer |
2023-10-04 17:14:13 | 200,000 0 |
200,000 | Form 4 |
| 16 | Carruthers R Michael Interim President / CFO |
2017-01-23 16:23:04 | 200,000 0 |
200,000 | Form 4 |
| 17 | Rodman David Malcom Exec Vice President and CMO |
2017-01-05 11:00:41 | 173,869 0 |
173,869 | Form 4 |
| 18 | Goldberg Zelanna Chief Medical Officer |
2021-06-02 18:16:36 | 160,000 0 |
160,000 | Form 4 |
| 19 | TIGER MANAGEMENT L.L.C. 10% Owner |
2019-02-12 13:52:55 | 0 137,728 |
137,728 | Form 4 |
| 20 | Litton Mark James See Remarks |
2019-02-08 16:30:19 | 100,000 0 |
100,000 | Form 4 |
| 21 | Sandler Andrew Seth Chief Medical Officer |
2023-01-05 19:32:19 | 50,000 0 |
50,000 | Form 4 |
| 22 | Shoemaker Steven VP Clinical R&D |
2015-09-15 16:32:21 | 39,700 0 |
39,700 | Form 4 |
| 23 | Gabriel Sherif Vice President Research |
2015-09-15 16:31:37 | 24,700 0 |
24,700 | Form 4 |
| 24 | Smith Cynthia Director |
2016-11-04 16:30:35 | 18,450 0 |
18,450 | Form 3 |
| 25 | MOORE JOHN R Director |
2016-09-14 16:16:18 | 12,300 0 |
12,300 | Form 4 |
| 26 | Loh Evan Director |
2016-09-14 16:16:04 | 12,300 0 |
12,300 | Form 4 |
| 27 | Furst Howard P. Director |
2016-09-14 16:16:04 | 12,300 0 |
12,300 | Form 4 |
| 28 | TROHA JANICE Exec Vice President / COO |
2017-05-09 14:01:27 | 10,000 0 |
10,000 | Form 4 |
| 29 | LEFF JONATHAN S Director |
2015-09-15 16:31:51 | 7,650 0 |
7,650 | Form 4 |
| 30 | SEKHRI PAUL J Director |
2020-01-06 20:02:57 | 7,650 0 |
7,650 | Form 4 |
| 31 | Peetz Christopher Director |
2024-05-20 20:14:39 | 0 0 |
0 | Form 4 |
| 32 | Hernday Natasha Director |
2024-05-20 20:13:47 | 0 0 |
0 | Form 4 |
| 33 | Drappa Jorn Director |
2024-05-20 20:12:51 | 0 0 |
0 | Form 4 |
| 34 | CONWAY ROBERT E Director |
2024-05-20 20:11:51 | 0 0 |
0 | Form 4 |
| 35 | Topper James N Director |
2024-05-20 20:10:44 | 0 0 |
0 | Form 4 |
| 36 | Thompson Peter A. Director |
2024-05-20 20:09:42 | 0 0 |
0 | Form 4 |
| 37 | Cui Xiangmin Decheng Capital China Life Sciences USD Fund III L.P. Decheng Capital Management III (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Director 10% Owner |
2024-05-21 16:49:22 | 0 0 |
0 | Form 13D |
| 38 | Rickey James Paul See Remarks |
2024-05-20 20:07:07 | 0 0 |
0 | Form 4 |
| 39 | PENG STANFORD L See Remarks |
2024-05-20 20:05:55 | 0 0 |
0 | Form 4 |
| 40 | GOLD MITCHELL Executive Chairman and CEO |
2024-05-20 20:04:51 | 0 0 |
0 | Form 4 |
| 41 | FUHS ULRICH MARTIN Chief Accounting Officer |
2024-05-20 20:03:58 | 0 0 |
0 | Form 4 |
| 42 | DURAND REMY Chief Business Officer |
2024-05-20 20:02:32 | 0 0 |
0 | Form 4 |
| 43 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director |
2024-05-20 19:47:32 | 0 0 |
0 | Form 4 |
| 44 | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Heron Patrick J Topper James N 10% Owner |
2024-05-21 10:21:59 | 0 0 |
0 | Form 13D |